# Peds3 Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/peds3-co

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.peds3.com
- Total disclosed funding: $0.8M
- Latest round: Seed (Oct 2, 2024)
- Investors on record: 1

## About

Based in Tokyo, Japan, and founded in 2023, Peds3 Co., Ltd., a.k.a. Peds3, engages in the research and development of therapeutic applications using a biopsychosocial model, which combines biological, psychological, and social factors, for children with learning disabilities, developmental disorders, psychiatric disorders, psychosomatic disorders, and anxiety disorders, as well as chronic diseases. The company also develops a medical platform for medical institutions to support developmental and pediatric medicine. In October 2024, Peds3 raised JPY 110 million in seed funding from Miyako Capital.

Peds3 focuses on developing digital solutions to enhance pediatric care by integrating online and offline medical services. The company’s main product is a pediatric therapeutic app aimed at providing biopsychosocial care for children with learning disabilities, developmental disorders like ADHD, psychiatric conditions such as orthostatic adjustment disorder, and chronic diseases like atopic dermatitis. The company is also involved in research and development to improve child development and maternal and child health. Peds3's platform supports medical institutions by offering a digital clinic that helps standardize care for pediatric patients across specialized and non-specialist healthcare facilities.

Peds3 plans to use its proceeds from October 2024 funding to invest in research and development and human resources to accelerate business expansion.

## Funding rounds

- Seed, Oct 2, 2024, $0.8M — Miyako Capital

## Investors

- Miyako Capital (https://capitalatlas.ai/funds/miyako-capital) — Seed